Authors: Cristina Popescu, PhD – Department of Oncogenetics, AMS Genetic Laboratory, Bucharest & Faculty of Medicine and Pharmacy, “Vasile Goldiş” Western University of Arad, Romania. Dr. Valeria Belengeanu – Faculty of Medicine and Pharmacy, “Vasile Goldiş” Western University of Arad, Romania. Abstract Over the past 10 years, we have seen major scientific advances in our understanding of cancer,...
Genetic testing is an area with explosive development. Their applicability is extremely wide and in essence they aim at an important coordinate of personalized medicine, respectively of adapting the approach and medical treatment to the specifics of each patient. We discussed genetic testing and the benefits it brings to patients with Dr. Cristina Popescu, PhD...
Cystoscopy combined with cytology is the currently recommended procedure for monitoring patients who have been diagnosed with bladder cancer and have undergone tumor removal surgery. Follow-up procedures are usually scheduled once every 3 months at the beginning and then twice a year and finally annually. A cystoscopy at each follow-up visit is burdensome for the...
This overview represents the updated European Association of Urology (EAU) Guidelines for Non-muscle-invasive Bladder Cancer (NMIBC), TaT1 and carcinoma in situ (CIS). The information presented is limited to urothelial carcinoma, unless specified otherwise. The aim is to provide practical recommendations on the clinical management of NMIBC with a focus on clinical presentation and recommendations. Read more
